ADP-ribosylation Factor-1 Stimulates Formation of Nascent Secretory Vesicles from the trans-Golgi Network of Endocrine Cells
Open accessAbstract
ADP-ribosylation factor (ARF) is a small GTP-binding protein that has been implicated in intracellular vesicular transport. ARF regulates the budding of vesicles that mediate endoplasmic reticulum to Golgi and intra-Golgi transport. It also plays an important role in maintaining the function and morphology of the Golgi apparatus. Using a permeabilized cell system derived from GH3 cells, we provide evidence that ARF-1 regulates the formation of nascent secretory vesicles from the trans-Golgi network. Both myristoylated and non-myristoylated forms of recombinant human ARF-1 enhanced secretory vesicle budding about 2-fold. A mutant lacking the first 17 N-terminal residues, as well as one that preferentially binds GDP (T31N) did not stimulate vesicle formation. In contrast, a mutant defective in GTP hydrolysis (Q71L) promoted vesicle budding. Strikingly, a peptide corresponding to the N terminus of human ARF-1 (amino acids 2-17) also stimulated vesicle budding from the trans-Golgi network, in marked contrast to its inhibitory effect on vesicular transport from the endoplasmic reticulum to Golgi. These data demonstrate that in endocrine cells, ARF-1 and in particular its N terminus play an essential role in the formation of secretory vesicles.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Previous studies have reported seemingly contradictory roles for GDP-bound Arf proteins (Arf-T31N) as either inactive mutants whose physiological effects do not differ from wildtype Arfs, or as dominant-negative mutants with inhibitory effects on vesicular transport and other cellular functions.
“Previous studies have reported seemingly contradictory roles for GDP-bound Arf proteins (Arf-T31N) as either inactive mutants whose physiological effects do not differ from wildtype Arfs [57], [58], or as dominant-negative mutants with inhibitory effects on vesicular transport and other cellular functions [59].”
From Arf4 Determines Dentate Gyrus-Mediated Pattern Separation by Regulating Dendritic Spine Development (2012) · cites this paper as [57]
Split into 2 atoms — 0 confirmed, 1 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No references could be resolved yet.
Research works printed but not linked: 1
- [1]1. Kahn, R.A. ∙ Gilman, A.G. J. Biol. Chem. 1984; 259:6228-6234
Cited by
Sorted by citations
Dense-core secretory granule biogenesis
Kim, T., Gondré-Lewis, M. C., Arnaoutova, I., & Loh, Y. P. (2006) · Physiology · doi:10.1152/physiol.00043.2005 · Cited by 203 · see citing works
Arf4 Determines Dentate Gyrus-Mediated Pattern Separation by Regulating Dendritic Spine Development
Jain, S., Yoon, S. Y., Zhu, L., Brodbeck, J., Dai, J., Walker, D., & Huang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046340 · Cited by 43 · see citing works
- Authors
- Chen, Y.-G., & Shields, D.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Shields, Dennis
- ORCID
- Chen, Ye-Guang
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-03
- Volume
- 271
- Issue
- 10
- Pages
- 5297-5300
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2072572288
- Cited by
- 68
- References
- 0
- Citations by year
- 2026: 2 · 2023: 1 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 3
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 09475, T32CA009475, P30CA013330)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-21860)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- Arf1, trans-Golgi network, vesicle formation, endocrine cells, GH3 cells, myristoylation, N-terminal peptide, GTP hydrolysis, GDP binding, Golgi apparatus
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cloning, Molecular, Cytoplasmic Granules, Cytosol, Escherichia coli, Golgi Apparatus, Humans, Kinetics, Molecular Sequence Data, Peptide Fragments, Pituitary Gland, Anterior, Recombinant Proteins, Mutagenesis, Site-Directed, Point Mutation, DNA Primers, GTP-Binding Proteins, ADP-Ribosylation Factors, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review